Nordic Healthcare Group (NHG)’s Post

Join our experts on March 27th at noon (EST) for a webinar on mastering reimbursement in #MedTech and #lifescience. Understanding your current reimbursement landscape is crucial for successful #commercialization, especially in the realm of women's health innovation. Fundamentally, #MedTechinnovators need to know what codes are applicable to their technology, whether their innovation is covered under those codes, and if there is appropriate payment assigned.   In collaboration with the Women's Health Innovation Series, Tonya Dowd, MPH, Executive Vice President, and Ryan Nolan, Director of Reimbursement, Value Generation, and Market Access, at PRIA Healthcare will simplify complexities and provide invaluable insights tailored for women's health technologies. As a trusted partner in the industry, #PRIA Healthcare offers vital resources and expertise to innovators in #FemTech, MedTech, and life science.   You’ll gain insights on: 🔹The fundamentals of reimbursement and market access in the context of early commercial product planning. 🔹The difference between U.S. FDA and CMS/payers requirements for MedTech. 🔹The Importance of early planning and why the reimbursement and market access plan should be integrated early in the process. 🔹A review of common industry misperceptions, and mistakes, and how to avoid them.   Space is limited for this exclusive session. Register today by clicking the link below to secure your seat! https://lnkd.in/eCDNgAVb   #medtech #femtech #medtechinnovation #medtechcommercialization #marketaccess #reimbursement Jeffrey Sirek, Stephanie DeFelice, eMBA, Marie A., Chelsy Peet, Meghan DeChello, Rebecca Baldwin, Daisy Gregson, Fiona Carlin, Kisaco Research

Engage in the discussion about the future of FemTech in Swedish healthcare! 🧩 We are proud to share the important work Maya Callens and Maria Andersson has done in collaboration with Nordic Healthcare Group to contribute to the The Future of FemTech in Swedish Healthcare. They completed their master's thesis from the Bioentrepreneurship program at Karolinska Institutet and passed with distinction with their study on how #FemTech; a growing sector in digital health technology, can be implemented in Sweden’s public healthcare system. Here are some highlighted challenges and opportunities from their work: Challenges 🔹Small and medium-sized enterprises (SMEs) within FemTech often lack the incentives and resources to integrate with public healthcare. Only 20% of public procurements require proof of efficacy --> highlighting the need for stricter evaluation standards. 🔹Successful use of digital health technologies requires collaboration between patients and healthcare providers. However, without engagement from medical professionals and decision-makers, these technologies risk falling through the cracks. 🔹Concerns around data privacy and discrimination remain significant challenges, especially in an industry that is largely consumer-focused. Opportunities 🔸Having product advocates among healthcare professionals can be crucial in driving the adoption of FemTech. 🔸Starting in the private sector can provide a pathway into public healthcare. 🔸Collaboration with already established companies can provide the credibility and resources needed to scale up. FemTech has the potential to revolutionize healthcare for women, but to truly make a difference, we need to overcome the existing barriers and leverage the identified opportunities. 💭 Are you interested on how you can support FemTech initiatives and create impactful change? Are you currently planning a procurement and looking for support to create inclusive requirements? Please reach out!

Department of Health and Social Care's Medical Technology Strategy Review Time and time again innovative medical technology (medtech) has advanced our quality of care. As we look ahead to the next 75 years of the NHS and social care system, medtech has never been so important as a catalyst for change to improve patient outcomes. That is why, in February 2023, we published the government’s inaugural medtech strategy. This set out how, over the next 5 to 10 years, we will ensure the health and social care system can reliably access safe, effective and innovative technologies. These technologies will enable the delivery of high-quality care, outstanding patient safety and excellent health outcomes, while making the best use of taxpayer money. Click here to read the report in full .. https://lnkd.in/eZvWwPSc Growth and M&A for Healthcare Technology companies Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit https://lnkd.in/ezyUh5i HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk  HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! https://lnkd.in/e5hTp_xb HealthTech Corporate Development and M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk  #HealthTech #HealthIT #DigitalHealth #lloydgprice #NelsonAdvisors https://lnkd.in/ev2z7Jsb

In the dynamic landscape of healthcare, unlocking clinical value is paramount for the success of any MedTech solution. Here are some study endpoints that our team came up with that often go overlooked and underused by our clients: 🚀 Feasibility studies conducted in clinical settings offer invaluable insights into the impact of your MedTech on patient outcomes and operational efficiency. By pinpointing the clinical value being driven, such as reducing length of stay, cutting costs of care, and facilitating timely discharge, you're not just introducing a product; you're revolutionizing healthcare delivery. 💡 Your economic models demonstrate the compelling reasons for integrating your MedTech into hospital systems. 🔑 But it doesn't stop there. As your study evolves, your messaging needs to adapt, ensuring alignment with your evolving needs and objectives. 🤝 Let's collaborate! Our team can help you navigate the intricate terrain of clinical workflows, ensuring seamless integration and optimal utilization of your technology. Remember, success hinges on more than just deployment; it's about ensuring that your team is equipped to leverage the full potential of your product. Our dedicated team stands ready to assist, ensuring a maximum impact on not just patient care, but clinical workflows too. #ClinicalTrials #ClinicalResearch #MedicalResearch #ResearchInnovation #ClinicalStudy #ClinicalScience #HealthResearch #ClinicalData #PatientRecruitment #MedTech #HealthTech #MedDevice #BioTech #Research

Technology has become an integral part of every industry and the same goes for the healthcare industry. However, a specific aspect of healthcare is much in need of revitalization; that is, the FemTech sector. This need to remake and revamp the industry has never been more urgent, as decades of neglect and underrepresentation have left women’s healthcare needs inadequately addressed. Hilla Shaviv, through her pioneering venture Gals Bio Ltd, is at the forefront of pushing the boundaries of what #femtech can achieve. Her work is ultimately about challenging and changing the very fabric of women’s healthcare. Her innovative diagnostic tool is a beacon of hope, signaling a shift towards a future where women’s health issues are no longer an afterthought but a central focus of healthcare innovation. #womenshealth https://lnkd.in/dQr4w-Cv

I recently had some really nice feedback about Inside MedTech and during the conversation was asked what the motivation was behind starting it. To be honest, it was really simple. I wanted to create a value-led MedTech community. Each and every day I get to speak to so many amazing people, gain unique insight into our incredible industry and hear so many inspirational stories. It is also apparent that most of the challenges we face in MedTech and wider, in Healthcare, are consistent and felt throughout the market. With that in mind, I wanted to create a platform that would allow those inspirational stories and unique insights to be heard (even if it was a little out of my comfort zone to begin with). The feedback I have received to date has meant a lot and I will continue to try and add value through insights and remain grateful to work in such an impactful industry. Keep on making a difference MedTech! (Oh, and join us for our next event on Friday August 16th, 16.00 BST / 11.00 EST - link in comments) #medtech #insidemedtech #executiveleadership #healthcare

Delighted to attend the first edition of #HLTHEurope on behalf of Health Technology Catalyst | CTS. Day 1 was already very promising with meeting representatives from #healthtechecosystems in Danemark🇩🇰, Portugal🇵🇹, France🇫🇷, and Belgium🇧🇪. Key takeaways from the “Accessing the US” 🇺🇸 workshop: From the Healthcare System Head of Innovation : Give us an incentive to work with you as a startup: warrants, equity, revenue sharing agreement etc. We can also consider negotiating a cost recovery structure type of contract. When choosing a US based accelerator, look for coaching and advice capabilities but more importantly: Access. Can the accelerator give you access to your targeted healthcare systems? Hot topics of the moment: IA and Ops: there is a huge need to reduce physician time. Radiology and imaging are always winners. RPM platform and wearables are sought after as long as they don’t add to the already overburdened schedule of primary physicians. From the Corporate Attorney: Work on your 4 Rs: Regulatory, Reimbursement, Rights (PI), Readiness (for commercialisation). Create an American Advisory Board and give themstock options (after thorough vetting). Never forget to measure health economics in your pilot and get the results published and reviewed by peers so that you don’t suffer from pilotitis. More to share tomorrow!

Are you attending THE MEDTECH EXPO & CONFERENCE OF 2024? Joining us as another 1st time exhibitor at Science & Engineering Health Technologies Alliance (SEHTA)'s 2024 International MedTech Expo & Conference on 1st November in London is InterSystems UKI. InterSystems, a creative data technology provider, delivers a unified foundation for next-generation applications for customers in more than 80 countries in the healthcare, finance, and manufacturing and supply chain sectors. Our approach revolves around a cloud-first data platform that integrates high performance database management, smart data services, and analytics capabilities. For 46 years, InterSystems has delivered the healthcare data platform for the world’s most proven electronic medical record systems used by health systems and governments. This is not just another event; it's a fantastic opportunity to gather insights and discuss the impacts on MedTech, funding, and commissioning in the coming year. With an expert team from across the industry, you can expect valuable discussions around pressing issues and exciting developments in healthcare. 🔍 ONLY 3 WEEKS TO GO!! So don't delay to connect with delegates from MedTech/Life Sciences SMEs, Clinicians, NHS Providers, Academics & Service Providers throughout the day. 🌟 Delegate fee starts from £400+VATpp & #NHS staff go FREE! (Ticket includes full day catering, access to expo & conference) For more info & to register visit http://www.bit.ly/47ChcRO #medtech #diagnostics #meddevice #digitalhealth #lifesciences #medicaldevices #innovators #startups #academics #clinicians #healthcare #healthtech #SMEs #AI #IVD #regulatory

When Will the Future of Healthcare Arrive? I’m not sure exactly when, but I know we’ll be discussing this—and many other fascinating topics—at The MedTech Conference in Toronto in just a couple of days! Browsing the agenda now, and I can already tell that the conference will be a great opportunity to dive into conversations with fellow medtech professionals about connected medical devices and how they are becoming integral parts of our evolving digital ecosystems of care. Here’s a sample of other discussion topics: 👉 Navigating the Intersection: Digital Health Innovations and Market Access Strategies 👉Artificial Intelligence in Medical Devices: Regulations That Keep on Learning 👉How AI/GenAI is Powering the Way MedTech Organizations Reshape Patient Care 👉Revolutionizing Medtech: Exploring Groundbreaking Models for Driving Innovation 👉Delivering Equitable Care in MedTech, and many more. ⁉ Not sure if this is new this year, but there will be a number of ‘reverse pitch presentations’ where executives of global medical device companies will outline their companies’ strategic priorities—including Mike Golebiowski, B. Braun Group; Charlie Attlan, Boston Scientific; Joseph Bianco, Abbott; Brian Montgomery, GE HealthCare; Donald E Bobo Jr, Edwards Lifesciences; Vishy Kanda, BD; Lisa Fawcett, CooperSurgical; Sonal Patel, Zimmer Biomet; Robyn Korkus, Terumo Blood and Cell Technologies; Jessica Hameline, Hologic, Inc.; Rajeev Varma, Haemonetics, and others. I can't wait for all the panels and discussions, and to connect with so many passionate people in the field. ✉ If you’re attending, drop me a line—let’s connect and chat about the future of medtech 💪💪💪

Wes Streeting outlines plans to transform Britain into a leading force in medical technology (MedTech). This article covers the proposed strategies to enhance innovation, support startups, and integrate cutting-edge technologies into the healthcare system. By fostering a supportive environment for MedTech, the aim is to improve healthcare services, create jobs, and position Britain as a global leader in medical technology. What would you add? Found this useful? Repost ♻️ to help your network. Join a community of 86,500+ HealthTech leaders finding the ideas, people, innovations and technologies that are shaping the future of healthcare. 👉 http://lnkd.in/eExMcaG6